Sign in
☰
People MPsHouse of LordsGovernmentOppositionPartiesCommittees Votes Commons votesLords votesVotes by issueTopicsStats & rankingsParliament in numbers Legislation BillsEarly day motionsPetitions Elections Election resultsConstituenciesWho is my MP? Scotland OverviewMSPsScottish GovernmentVotesBillsMotionsCommitteesConstituencies & regionsElections Search Sign in

Early day motion · EDM 208 · 1 Jun 2026

Enhertu for metastatic breast cancer patients

Tabled by Clive Jones (Liberal Democrat) 51 signatures

The motion

That this House recognises the recent changes to NICE’s cost effectiveness threshold, which could facilitate better access to new medicines; expresses concern that Enhertu, a treatment for people with incurable HER2-low metastatic breast cancer, remains unavailable to patients on the NHS in England; welcomes Breast Cancer Now's Enhertu Now campaign, supported by METUPUK and Make 2nds Count; and urges pharmaceutical companies Daiichi Sankyo and AstraZeneca, NHS England and NICE to reach a deal to make Enhertu available to those who urgently need it to give them more time to live.

Signatories (51)

Source: the official Early Day Motions database.